Diabetic Macular Edema (DME) Not Yet Recruiting Phase Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

DBCOND0060562 (Diabetic Macular Edema (DME))Not Yet RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06398080An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting
NCT04856397Ozurdex in Suboptimal Diabetic Macular Edema PatientsTreatment